Iran vs Sri Lanka: Cause of death, by non-communicable diseases, ages 5-14
Iran
42.5%
in 2021
Sri Lanka
43.2%
in 2021
Iran rank
72nd
Sri Lanka rank
69th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Iran
- Sri Lanka
How they compare
Sri Lanka currently reports 43.2% against 42.5% in Iran, a difference of 0.7%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Sri Lanka ahead.
Iran ranks 72nd and Sri Lanka ranks 69th of 185 countries.
Across the 3 decades both report, Iran averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Iran | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.6% | 41.7% | 4.1% | Sri Lanka |
| 2010s | 44.0% | 38.0% | 6.0% | Iran |
| 2020s | 44.8% | 44.9% | 0.1% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Iran or Sri Lanka?
- Sri Lanka, at 43.2% against 42.5% in Iran as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Iran and Sri Lanka?
- 0.7%, with Sri Lanka ahead.
- How many years of comparable data are there for Iran and Sri Lanka?
- 6 years are reported by both, from 2000 to 2021.
- How do Iran and Sri Lanka rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Iran ranks 72nd and Sri Lanka ranks 69th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.